Phaarmasia Balance Sheet Annual

BSE: 523620 | NSE: - | ISIN: INE486I01016 | Sector: Biotechnology & Drugs

86.20 -1.80 (-2.05%)Updated : 11 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	30.06	21.56	31.45	28.42
Cash Equivalents	0.32	0.21	0.49	0.55
Other Liabilities Total	0.22	0.22	0.22	0.18
Common Stock Total	6.83	6.83	6.83	6.83
Other Current Assets Total	6.26	1.68	0.79	0.49
Total Assets	30.06	21.56	31.45	28.42
Current Portof LT Debt/ Capital Leases	0.00	0.01	0.13	0.12
Cash	10.67	0.16	0.15	0.14
Total Equity	22.10	8.74	10.30	10.81
Long Term Investments	0.00	0.06	0.05	0.05
Retained Earnings( Accumulated Deficit)	15.27	1.91	3.47	3.98
Total Common Shares Outstanding	0.00	0.00	0.00	0.00
Total Liabilities	7.96	12.82	21.15	17.61
Total Debt	1.12	0.01	0.14	0.27
Cashand Short Term Investments	10.99	0.36	0.63	0.69
Total Receivables Net	5.13	3.11	8.05	7.51
Notes Payable/ Short Term Debt	1.12	0.00	0.00	0.00
Deferred Income Tax	0.02	0.00	-	0.00
Accounts Receivable- Trade Net	5.13	3.11	8.05	7.51
Property/ Plant/ Equipment Total- Net	1.03	12.29	12.44	12.75
Total Current Liabilities	7.72	12.61	20.91	17.28
Total Inventory	4.36	3.06	8.50	6.36
Accounts Payable	2.12	11.96	20.08	16.54
Other Currentliabilities Total	4.48	0.63	0.70	0.62
Intangibles Net	0.03	0.03	0.03	0.03
Other Long Term Assets Total	2.27	0.97	0.95	0.54
period Length	0.00	0.00	0.00	0.00
Total Current Assets	26.74	8.21	17.97	15.04
Long Term Debt	-	0.00	-	0.00
Other Equity Total	-	0.00	-	-
Total Long Term Debt	-	0.00	0.01	0.14
Capital Lease Obligations	-	0.00	0.01	0.14